GPRC5B
G-protein coupled receptor family C group 5 member B
Also known as: GPC5B_HUMAN, RAIG-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZH0
- Gene
- GPRC5B
- Ensembl
- ENSG00000167191
- Chromosome
- 16
- Canonical length
- 403 aa
- Protein class
- G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Vesicles
OverviewNCBI Gene
This gene encodes a member of the type 3 G protein-coupled receptor family. Members of this superfamily are characterized by a signature 7-transmembrane domain motif. The encoded protein may modulate insulin secretion and increased protein expression is associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Canonical amino-acid sequenceUniProt
403 residues, UniProt reviewed canonical sequence.
>Q9NZH0|GPRC5B
1 MFVASERKMR AHQVLTFLLL FVITSVASEN ASTSRGCGLD LLPQYVSLCD LDAIWGIVVE
61 AVAGAGALIT LLLMLILLVR LPFIKEKEKK SPVGLHFLFL LGTLGLFGLT FAFIIQEDET
121 ICSVRRFLWG VLFALCFSCL LSQAWRVRRL VRHGTGPAGW QLVGLALCLM LVQVIIAVEW
181 LVLTVLRDTR PACAYEPMDF VMALIYDMVL LVVTLGLALF TLCGKFKRWK LNGAFLLITA
241 FLSVLIWVAW MTMYLFGNVK LQQGDAWNDP TLAITLAASG WVFVIFHAIP EIHCTLLPAL
301 QENTPNYFDT SQPRMRETAF EEDVQLPRAY MENKAFSMDE HNAALRTAGF PNGSLGKRPS
361 GSLGKRPSAP FRSNVYQPTE MAVVLNGGTI PTAPPSHTGR HLWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPRC5B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 213 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 213 nTPM
- basal ganglia: 201 nTPM
- cerebral cortex: 172 nTPM
- hippocampal formation: 167 nTPM
- midbrain: 164 nTPM
- amygdala: 155 nTPM
Single-cell type
- oligodendrocytes: 389 nCPM
- late spermatids: 326 nCPM
- bergmann glia: 309 nCPM
- early spermatids: 268 nCPM
- astrocytes: 258 nCPM
- oligodendrocyte progenitor cells: 138 nCPM
Immune cell
- naive CD4 T-cell: 2.8 nTPM
- intermediate monocyte: 0.7 nTPM
- memory CD4 T-cell: 0.7 nTPM
- total PBMC: 0.5 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- white matter: 1,043 nTPM
- basal ganglia: 949 nTPM
- medulla oblongata: 868 nTPM
- cerebellum: 829 nTPM
- midbrain: 743 nTPM
- thalamus: 719 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GPRC5B.
Disease | AllUniProt
Conditions GPRC5B is implicated in, by any mechanism.
- Megalencephalic leukoencephalopathy with subcortical cysts 3 (MLC3) MIM:620447
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 81 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Megalencephalic leukoencephalopathy with subcortical cysts 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- G protein-coupled receptor activity
- G protein-coupled receptor binding
- protein kinase activator activity
- protein kinase binding
- protein tyrosine kinase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPRC5B as an antibody target. Whether an autoantibody or antibody against GPRC5B could matter depends on whether native GPRC5B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPRC5B is annotated at the cell surface, where native GPRC5B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPRC5B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...